Merck Kgaa (MRK.D.DX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [DXE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [DXE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Accounts receivable | 79,000 | -8,000 | -413,000 | -310,000 | -84,000 |
| Other Working Capital | -310,000 | -707,000 | -1,082,000 | -274,000 | -395,000 |
| Other Operating Activity | 4,817,000 | 4,499,000 | 5,754,000 | 5,200,000 | 3,956,000 |
| Operating Cash Flow | $4,586,000 | $3,784,000 | $4,259,000 | $4,616,000 | $3,477,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,675,000 | -1,788,000 | -1,510,000 | -1,059,000 | -1,378,000 |
| Net Acquisitions | -767,000 | -12,000 | -850,000 | -4,000 | 36,000 |
| Purchase Of Investment | N/A | -537,000 | -364,000 | -269,000 | -778,000 |
| Sale Of Investment | N/A | 510,000 | 219,000 | 70,000 | 841,000 |
| Purchase Sale Intangibles | -464,000 | -80,000 | -237,000 | -316,000 | -62,000 |
| Other Investing Activity | -126,000 | 151,000 | 37,000 | 39,000 | 89,000 |
| Investing Cash Flow | $-3,050,000 | $-1,892,000 | $-2,743,000 | $-1,578,000 | $-1,340,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -177,000 | -845,000 | 54,000 | -1,508,000 | -605,000 |
| Debt Issued | 683,000 | 697,000 | 2,632,000 | 471,000 | 2,876,000 |
| Debt Repayment | -453,000 | -420,000 | -3,274,000 | -710,000 | -3,106,000 |
| Dividend Paid | -284,000 | -284,000 | -239,000 | -181,000 | -168,000 |
| Other Financing Activity | -754,000 | -880,000 | -728,000 | -576,000 | -519,000 |
| Financing Cash Flow | $-985,000 | $-1,732,000 | $-1,555,000 | $-2,504,000 | $-1,522,000 |
| Exchange Rate Effect | -16,000 | -31,000 | -7,000 | 9,000 | -40,000 |
| Beginning Cash Position | 1,982,000 | 1,854,000 | 1,899,000 | 1,355,000 | 781,000 |
| End Cash Position | 2,517,000 | 1,982,000 | 1,854,000 | 1,899,000 | 1,355,000 |
| Net Cash Flow | $551,000 | $160,000 | $-39,000 | $534,000 | $615,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 4,586,000 | 3,784,000 | 4,259,000 | 4,616,000 | 3,477,000 |
| Capital Expenditure | -2,184,000 | -2,023,000 | -1,806,000 | -1,421,000 | -1,563,000 |
| Free Cash Flow | 2,402,000 | 1,761,000 | 2,453,000 | 3,195,000 | 1,914,000 |